Article Versions Notes

Yeom D-H, Lee Y-S, Ryu I, Lee S, Sung B, Lee H-B, Kim D, Ahn J-H, Ha E, Choi Y-S, et al. ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models. International Journal of Molecular Sciences. 2021; 22(1):241. https://doi.org/10.3390/ijms22010241

Yeom, Dong-Hoon, Yo-Seob Lee, Ilhwan Ryu, Sunju Lee, Byungje Sung, Han-Byul Lee, Dongin Kim, Jin-Hyung Ahn, Eunsin Ha, Yong-Soo Choi, and et al. 2021. "ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models" International Journal of Molecular Sciences 22, no. 1: 241. https://doi.org/10.3390/ijms22010241

Yeom, D. -H., Lee, Y. -S., Ryu, I., Lee, S., Sung, B., Lee, H. -B., Kim, D., Ahn, J. -H., Ha, E., Choi, Y. -S., Lee, S. H., & You, W. -K. (2021). ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models. International Journal of Molecular Sciences, 22(1), 241. https://doi.org/10.3390/ijms22010241